Sentence examples for will only demonstrate from inspiring English sources

Obviously, these old and new policy measures will only demonstrate their effectiveness if they match the day-to-day behaviour of the transport users these measures are aimed at.

Opera has confirmed to us that the touch browser will also by shown running on Windows 7 notebooks at CES, but says it will only demonstrate a public preview, and that a public download release will be something for the future.

"Somehow this news will only demonstrate that the blockade and the aggression come from Washington DC, when it's the Cuban government that is a predator of freedom of information," Lazo told VICE News.

The power of an entrenched monopoly can be almost impossible for other companies to break, and so an examination of market share will only demonstrate that fact.

Ask what jargon means: Where jargon exists in application guidelines, don't be reluctant to ask for clarification on meaning as this will not only demonstrate a willingness to get it right, but it will also save time for both yourself and the funder in assessing your application.

It will not only demonstrate what works well within your talent management strategy, but also provide valuable information on persisting talent gaps, which may be fed directly back into thinking strategically.

Vallejo, a former president of the University of Chile student union, says the election to congress of student leaders "will not only demonstrate that the social movements can and should have their own representatives in congress, but also make it possible … to build political spaces that allow us to make the structural changes our society demands".

There was no doubt that the resolution in Geneva would pass, but this will only further demonstrate the impotence of lukewarm diplomacy.

It should be noted that, whilst such dichotomization is useful in demonstrating associations with outcome, true utility of ERβ variant mRNA measurement will only be demonstrated with larger patient cohorts and may be better achieved by treating mRNA quantitation as a continuous variable, as in other RTPCR based outcome predictors [ 24].

The eventual impact of these initiatives will only be demonstrated if there is a fall in disease-specific mortality rate.

Perhaps this serves to underline the unreliability of comparisons between different phase II studies; a true dose-intensity benefit will only be demonstrated with a prospective randomised trial.